BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 27055150)

  • 1. Serological and clinical profile of systemic sclerosis: analysis in a cohort of patients from a single center in Northern Italy.
    Priora M; Manetta T; Scarati M; Parisi S; Laganà A; Peroni CL; Bruzzone M; Borrelli R; Rende M; Mengozzi G; Fusaro E
    G Ital Dermatol Venereol; 2018 Feb; 153(1):33-38. PubMed ID: 27055150
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serological profile of patients with systemic sclerosis.
    Wielosz E; Dryglewska M; Majdan M
    Postepy Hig Med Dosw (Online); 2014 Aug; 68():987-91. PubMed ID: 25228505
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of a novel particle-based multi-analyte technology for the detection of anti-fibrillarin antibodies.
    Mahler M; Kim G; Roup F; Bentow C; Fabien N; Goncalves D; Palterer B; Fritzler MJ; Villalta D
    Immunol Res; 2021 Jun; 69(3):239-248. PubMed ID: 33913080
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autoantibody profiles in systemic sclerosis: predictive value for clinical evaluation and prognosis.
    Hamaguchi Y
    J Dermatol; 2010 Jan; 37(1):42-53. PubMed ID: 20175839
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of anti-U3-RNP/fibrillarin IgG antibodies by line immunoblot assay has comparable clinical significance to immunoprecipitation testing in systemic sclerosis.
    Peterson LK; Jaskowski TD; Mayes MD; Tebo AE
    Immunol Res; 2016 Apr; 64(2):483-8. PubMed ID: 26467972
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RNA polymerase III autoantibodies may indicate renal and more severe skin involvement in systemic sclerosis.
    Terras S; Hartenstein H; Höxtermann S; Gambichler T; Kreuter A
    Int J Dermatol; 2016 Aug; 55(8):882-5. PubMed ID: 26499848
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-Th/To are common antinucleolar autoantibodies in Italian patients with scleroderma.
    Ceribelli A; Cavazzana I; Franceschini F; Airò P; Tincani A; Cattaneo R; Pauley BA; Chan EK; Satoh M
    J Rheumatol; 2010 Oct; 37(10):2071-5. PubMed ID: 20682663
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-U1RNP antibodies are associated with a distinct clinical phenotype and a worse survival in patients with systemic sclerosis.
    Chevalier K; Chassagnon G; Leonard-Louis S; Cohen P; Dunogue B; Regent A; Thoreau B; Mouthon L; Chaigne B
    J Autoimmun; 2024 Jun; 146():103220. PubMed ID: 38642508
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Optimization and diagnostic performance of a single multiparameter lineblot in the serological workup of systemic sclerosis.
    Bonroy C; Van Praet J; Smith V; Van Steendam K; Mimori T; Deschepper E; Deforce D; Devreese K; De Keyser F
    J Immunol Methods; 2012 May; 379(1-2):53-60. PubMed ID: 22446156
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Distinctive autoantibody profile in Mexican Mestizo systemic sclerosis patients.
    Rodriguez-Reyna TS; Hinojosa-Azaola A; Martinez-Reyes C; Nuñez-Alvarez CA; Torrico-Lavayen R; García-Hernández JL; Cabiedes-Contreras J
    Autoimmunity; 2011 Nov; 44(7):576-84. PubMed ID: 21875377
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence and clinical associations of anti-Ku antibodies in patients with systemic sclerosis: a European EUSTAR-initiated multi-centre case-control study.
    Rozman B; Cucnik S; Sodin-Semrl S; Czirják L; Varjú C; Distler O; Huscher D; Aringer M; Steiner G; Matucci-Cerinic M; Guiducci S; Stamenkovic B; Stankovic A; Kveder T
    Ann Rheum Dis; 2008 Sep; 67(9):1282-6. PubMed ID: 18063672
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Presence of anti-eukaryotic initiation factor-2B, anti-RuvBL1/2 and anti-synthetase antibodies in patients with anti-nuclear antibody negative systemic sclerosis.
    Pauling JD; Salazar G; Lu H; Betteridge ZE; Assassi S; Mayes MD; McHugh NJ
    Rheumatology (Oxford); 2018 Apr; 57(4):712-717. PubMed ID: 29294089
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preliminary analysis of the very early diagnosis of systemic sclerosis (VEDOSS) EUSTAR multicentre study: evidence for puffy fingers as a pivotal sign for suspicion of systemic sclerosis.
    Minier T; Guiducci S; Bellando-Randone S; Bruni C; Lepri G; Czirják L; Distler O; Walker UA; Fransen J; Allanore Y; Denton C; Cutolo M; Tyndall A; Müller-Ladner U; Matucci-Cerinic M; ;
    Ann Rheum Dis; 2014 Dec; 73(12):2087-93. PubMed ID: 23940211
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical and laboratory features of African-Brazilian patients with systemic sclerosis.
    Mendes C; Viana VST; Pasoto SG; Leon EP; Bonfa E; Sampaio-Barros PD
    Clin Rheumatol; 2020 Jan; 39(1):9-17. PubMed ID: 31065858
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Frequency of disease-associated and other nuclear autoantibodies in patients of the German Network for Systemic Scleroderma: correlation with characteristic clinical features.
    Mierau R; Moinzadeh P; Riemekasten G; Melchers I; Meurer M; Reichenberger F; Buslau M; Worm M; Blank N; Hein R; Müller-Ladner U; Kuhn A; Sunderkötter C; Juche A; Pfeiffer C; Fiehn C; Sticherling M; Lehmann P; Stadler R; Schulze-Lohoff E; Seitz C; Foeldvari I; Krieg T; Genth E; Hunzelmann N
    Arthritis Res Ther; 2011; 13(5):R172. PubMed ID: 22018289
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of anti-IFI16 antibodies by ELISA: clinical and serological associations in systemic sclerosis.
    Costa S; Mondini M; Caneparo V; Afeltra A; Airò P; Bellisai F; Faggioli P; Gerli R; Lotzniker M; Meroni PL; Morozzi G; Radice A; Riccieri V; Scarsi M; Sebastiani GD; Sinico RA; Tincani A; Gariglio M; Landolfo S
    Rheumatology (Oxford); 2011 Apr; 50(4):674-81. PubMed ID: 21134960
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systemic Sclerosis-Specific Antibodies: Novel and Classical Biomarkers.
    Cavazzana I; Vojinovic T; Airo' P; Fredi M; Ceribelli A; Pedretti E; Lazzaroni MG; Garrafa E; Franceschini F
    Clin Rev Allergy Immunol; 2023 Jun; 64(3):412-430. PubMed ID: 35716254
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Nuclear auto-antibodies: a useful tool for the diagnosis, the classification and the prognosis of systemic sclerosis].
    Hachulla E; Dubucquoi S
    Rev Med Interne; 2004 Jun; 25(6):442-7. PubMed ID: 15158315
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnostic accuracy and predictive value of extended autoantibody profile in systemic sclerosis.
    Villalta D; Imbastaro T; Di Giovanni S; Lauriti C; Gabini M; Turi MC; Bizzaro N
    Autoimmun Rev; 2012 Dec; 12(2):114-20. PubMed ID: 22776784
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Disease subsets, antinuclear antibody profile, and clinical features in 127 French and 247 US adult patients with systemic sclerosis.
    Meyer OC; Fertig N; Lucas M; Somogyi N; Medsger TA
    J Rheumatol; 2007 Jan; 34(1):104-9. PubMed ID: 17117486
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.